![Jim Murray](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Jim Murray worked as the Head of Clinical Operations at Rhythm Pharmaceuticals, Inc. from 2017 to 2019, and at Merrimack Pharmaceuticals, Inc. from 2003 to 2017.
He also worked as the Vice President of Clinical at TScan Therapeutics, Inc. Additionally, he worked as the Head of Clinical Operations at Repertoire Immune Medicines, Inc. from 2019 to 2021.
Mr. Murray received his undergraduate degree from Boston College.
Former positions of Jim Murray
| Companies | Position | End |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 05/02/2024 |
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Corporate Officer/Principal | 28/02/2021 |
| RHYTHM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 31/07/2019 |
| MERRIMACK PHARMACEUTICALS | Corporate Officer/Principal | 28/02/2017 |
Training of Jim Murray
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
35
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Rhythm Pharmaceuticals, Inc.
 Rhythm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies peptide therapeutics for rare neuroendocrine diseases | Health Technology |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TScan Therapeutics, Inc.
 TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Health Technology |
- Stock Market
- Insiders
- Jim Murray
